ChannelAdvisor IPO ...
Health Care: Drugs
Mylan Inc (MYL: NASDAQ)
$31.75 0.20 | 0.63%
05/23/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 642.93M | 538.80M | 345.54M | 247.75M |
| Operating Gains/Losses | 0.00 | 48.56M | 127.06M | 163.32M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -354.84M | -318.87M | 21.86M | -175.80M |
| (Increase) Decrease in Inventories | -172.02M | -220.60M | -94.73M | 20.11M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 81.43M | 133.67M | 23.02M | 4.24M |
| (Decrease) Increase In Other Current Liabilities | -49.99M | 96.94M | 135.06M | -115.80M |
| (Increase) Decrease In Other Working Capital | -177.13M | -161.40M | -227.65M | 2.79M |
| Other Non-Cash Items | 540.96M | 150.05M | 167.17M | 211.95M |
| Net Cash From Continuing Operations | 949.02M | 720.42M | 931.40M | 605.08M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 949.02M | 720.42M | 931.40M | 605.08M |
| Sale of Property, Plant & Equipment | 16.34M | 0.00 | 4.95M | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 8.06M | 0.00 | 4.57M | 15.72M |
| Purchases of Property, Plant & Equipment | -305.32M | -279.85M | -192.79M | -154.40M |
| Acquisitions | 0.00 | -80.51M | -562.76M | -187.44M |
| Purchases of Short-Term Investments | -9.88M | 0.00 | -7.52M | 0.00 |
| Other Cash from Investing Activities | -73.43M | 38.34M | 28.15M | -8.88M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -364.24M | -332.04M | -725.41M | -335.00M |
| Issuance of Debt | 2.04B | 1.46B | 2.36B | 15.02M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 143.88M | 67.74M | 54.65M | 19.62M |
| Repayment of Long-Term Debt | -2.00B | -1.64B | -2.14B | -350.03M |
| Repurchase of Capital Stock | -999.89M | -350.00M | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | -139.04M | -139.04M |
| Other Financing Charges, Net | 199.53M | -176.54M | -27.42M | 0.00 |
| Net Cash From Financing Activities | -611.52M | -645.00M | 100.35M | -454.43M |
| Effect of Exchange Rate Changes | 1.65M | -30.38M | -24.81M | 7.72M |
| Net Change in Cash & Cash Equivalents | -25.09M | -287.00M | 281.54M | -176.63M |
Portfolios with MYL
- Portfolio NameUser Type
- ProJohn Paulson
- ContributorRocket Stocks for the Week ...
- ContributorPharmaceutical Short Squeez...
- UserPerpetual growers
- ProD.E. Shaw
- Contributor8 Pharma Stocks to Watch
- ContributorRocket Stocks for the Week ...
- UserLA
- Contributor12 'Conviction Buys' on Gol...
- UserWatch List - Healthcare / B...
Latest MYL Headlines from TheStreet
- Mylan Becomes #17 Most Shorted Nasdaq 100 Component, Replacing Akamai Technologies 05.10.13 | 03:05 pm
- 20 S&P500 Stocks Reporting Earnings This Week With History Of Upside 04.29.13 | 01:04 pm
- Merz Withdrawal Frees Obagi-Valeant Merger 04.09.13 | 01:04 pm
- Analysts' Actions: BTU JAZZ MYL SKUL TDG 03.11.13 | 08:03 am
- 5 Rocket Stocks to Buy Before the World Ends 12.17.12 | 10:12 am
- Paulson & Co Third Quarter Stock Holding 11.30.12 | 01:11 pm
- Analysts' Actions: AEO CIT GPS JBLU GME 11.16.12 | 08:11 am
- Boring Is Beautiful 10.02.12 | 06:10 am
- Buy the 5 Pharma Stocks Everyone Hates 08.07.12 | 11:08 am
- Mylan Management Discusses Q2 2012 Results - Earnings Call Transcript 07.26.12 | 03:07 pm
Press Releases for MYL
- Mylan Schedules First Quarter 2013 Financial Results Conference Call And Live Webcast - PR Newswire 04.09.13 | 08:04 am
- Mylan Launches First Generic Version Of Zovirax® Ointment - PR Newswire 04.03.13 | 03:04 pm
- Mylan Launches Generic Version Of Xopenex® Inhalation Solution - PR Newswire 03.18.13 | 11:03 am
- Mylan Announces Fortamet® Settlement Agreement - PR Newswire 03.13.13 | 03:03 pm
- Mylan Files Annual Report On Form 10-K For Year Ended Dec. 31, 2012 - PR Newswire 03.04.13 | 04:03 pm
- Mylan To Acquire Agila To Create Leading Global Injectables Platform - PR Newswire 02.27.13 | 04:02 pm
- Mylan Launches Generic Antara® Capsules - PR Newswire 02.25.13 | 08:02 am
- Mylan Launches Innovative Portfolio Of Antiretroviral Products For Treatment Of HIV/AIDS In South Africa - PR Newswire 02.23.13 | 11:02 am
- Thousands Of Schools Nationwide Are Receiving Free EpiPen(R) (epinephrine) Auto-Injectors Through The Mylan Specialty L.P. EpiPen4Schools(TM) Program - PR Newswire 02.20.13 | 09:02 am
- Mylan Enhances Partnership With Biocon Through Strategic Collaboration For Insulin Products - PR Newswire 02.13.13 | 04:02 pm
Partner Headlines for MYL
- Futures Steer Sharply Higher; IBD 50 Stock Mylan Spikes - Investor's Business Daily 03.06.13 | 08:03 am
- Stocks At Highs, Retain Gains; Alaska Air Hits High - Investor's Business Daily 03.05.13 | 03:03 pm
- Market Close Report: NASDAQ Composite index closes at 3,160.19 down -2.07 points - NASDAQ 02.28.13 | 09:02 pm
- Stocks Strengthen For Solid Feb. Gains; Not Catamaran - Investor's Business Daily 02.28.13 | 03:02 pm
- Stocks Open Down, Turn Mixed; Mylan, Monster Beverage Gap Up - Investor's Business Daily 02.28.13 | 10:02 am
- 3 Industries Set To Profit From An Aging Population - Seeking Alpha 01.31.13 | 09:01 am
- Raptor To Rise On Proven Strategy & Upcoming FDA Decision - Seeking Alpha 12.28.12 | 09:12 am
- Generic Unit at Mylan Boosted - Analyst Blog - Zacks 12.06.12 | 09:12 am
- Hi-Tech Pharmacal Set To Drop By 60% On Earnings And Fraud Investigations - Seeking Alpha 11.29.12 | 09:11 am
- Another Generic from Dr. Reddy's - Analyst Blog - Zacks 11.23.12 | 09:11 am
